Intestinal Carcinoma — Trials

Intestinal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,268 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 409
Recruiting: 235
Ph III recruiting: 16
Growth YoY: +6%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (150)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06937567	CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors	recruiting	Early Phase 1	36	Zhejiang UniversityOTHER	1	May 26, 2026	clinicaltrials
NCT03594630	Active Surveillance and Chemotherapy Before Surgery in Treating Participants With Stage II-III Rectal Cancer	recruiting	Early Phase 1	120	M.D. Anderson Cancer CenterOTHER	1	May 20, 2026	clinicaltrials